People trust FDA, unsure if it performs

Share this article:
Results of a new consumer survey on drug safety released by American University's Center for Congressional and Presidential Studies indicate that 82% of Americans surveyed trust the FDA on prescription drug issues, but only 53% rate the agency's work as “excellent” or “good,” while 47% say it is “fair” or “poor.”

Overall, those 18 to 34 years old were more positive on the FDA, while senior citizens—and especially men—were more negative. The survey was part of the center's program “A Dialogue on Prescription Drug Safety: Seeking Common Ground,” funded by Pfizer to examine efforts by policymakers to enhance America's prescription drug safety system and reform the FDA.

While 88% of those surveyed are confident in the safety of prescription drugs made in the US, that number falls off to 56% for drugs made in Europe and Canada and 14% for drugs made in India and China.

Some 64% of those surveyed said the US health system is “broken,” and more than 75% said prescription drug safety is at least somewhat important to them in deciding for whom to vote in the 2008 presidential election.

The FDA is the most trusted organization on prescription drug issues (82%), followed by patient advocacy groups (74%), drug companies (67%), and Congress (53%). Half of those surveyed said they are skeptical of Congress' ability to pass “common-sense” laws governing how the FDA approves drugs.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.